Preprint

DKFZ-2025-02738

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer

Müller, J. (First author)DKFZ* ; Sofyali, E.DKFZ* ; Schwarzmüller, L.DKFZ* ; Aylon, Y. ; Weizman, E. ; Schlicker, L.DKFZ* ; Kelly, K.DKFZ* ; Borgoni, S.DKFZ* ; Oz, S. ; Stocker, C.DKFZ* ; Burmester, S.DKFZ* ; Wörner, A.DKFZ* ; Karolus, S.DKFZ* ; Michels, B.DKFZ* ; Heiss, D.DKFZ* ; Will, R.DKFZ* ; Rodrigues de Melo Costa, V.DKFZ* ; Lutsik, P.DKFZ* ; Weichenhan, D.DKFZ* ; Hofmann, I.DKFZ* ; Belugali Nataraj, N. ; Yarden, Y. ; Magnani, L. ; Plass, C.DKFZ* ; Schulze, A.DKFZ* ; Körner, C.DKFZ* ; Oren, M. ; Wiemann, S. (Last author)DKFZ*

2025

Note: #EA:B050#LA:B050# / https://www.biorxiv.org/content/10.1101/2025.10.17.682994v1.full.pdf

---

Contributing Institute(s):

1. B050 Molekulare Genomanalyse (B050)
2. Metabolismus und Microenvironment (A410)
3. Epigenomik (B370)
4. Zelluläre Tools (W111)
5. Monoklonale Antikörper (W170)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2025

---